Updated overall survival analysis in oceans, a randomized phase 3 trail of gemcitabine (G) + carboplatin (C) and bevacizumab (BV) or placebo (PL) followed by BV or PL in platinum-sensitive recurrent epithelial ovarian (ROC), primary peritoneal (PPC), or fallopian tube cancer (FTC) Meeting Abstract
| Authors: | Aghajanian, C.; Nycum, L. R.; Goff, B.; Nguyen, H.; Husain, A.; Blank, S. V. |
| Abstract Title: | Updated overall survival analysis in oceans, a randomized phase 3 trail of gemcitabine (G) + carboplatin (C) and bevacizumab (BV) or placebo (PL) followed by BV or PL in platinum-sensitive recurrent epithelial ovarian (ROC), primary peritoneal (PPC), or fallopian tube cancer (FTC) |
| Meeting Title: | 37th Congress of the European Society for Medical Oncology (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 23 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2012 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2012-09-01 |
| Start Page: | ix319 |
| Language: | English |
| ACCESSION: | WOS:000309409001448 |
| PROVIDER: | wos |
| PUBMED: | 23012731 |
| DOI: | 10.1093/annonc/mds401 |
| Notes: | Meeting Abstract: 967O -- "Source: Wos" |
